The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 227.50
Bid: 226.50
Ask: 228.00
Change: 2.00 (0.89%)
Spread: 1.50 (0.662%)
Open: 228.00
High: 228.50
Low: 224.50
Prev. Close: 225.50
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: FTSE 100 catches up with bank holiday rally

Tue, 29th Aug 2023 09:03

(Alliance News) - Stock prices in London opened higher on Tuesday, as UK markets return from a long bank holiday weekend and news that UK shop price inflation decelerated in August.

London's equities were also catching up with a strong European session on Monday, prompted by developments in China and well-received comments from US Federal Reserve Chair Jerome Powell on Friday.

In China, markets extended Monday's rally after China's regulators decided to slash the tax paid on stock trades for the first time since 2008.

The FTSE 100 index opened up 116.73 points, 1.6%, at 7,455.31. The FTSE 250 was up 284.59 points, 1.6%, at 18,415.61, and the AIM All-Share was up 5.96 points, 0.8%, at 739.63.

The Cboe UK 100 was up 1.4% at 742.14, the Cboe UK 250 was up 1.5% at 16,089.35, and the Cboe Small Companies was up 0.1% at 13,426.98.

In early economic news, UK shop price inflation decelerated further in August, data showed on Tuesday, presenting some "better news for consumers".

According to the latest British Retail Consortium-NielsenIQ tracker, the annual shop price inflation rate cooled to 6.9% in August from 8.4% in July. This was below the three-month average of 8.0% and the lowest rate since October 2022.

Food inflation slowed to 11.5% in August from 13.4% in July, while non-food inflation remained at 4.7%.

UK holidaymakers were also hit by travel disruption on Monday, which could last for days. Flights were cancelled leaving thousands of passengers stranded following an air traffic control technical fault.

By Monday afternoon, 232 flights departing UK airports had been cancelled and 271 arriving flights, according to aviation analytics firm Cirium.

On the back of the news, Ryanair lost 0.3% in Dublin. However, Wizz Air rose 3.1% and easyJet was up 2.0%.

The pound was quoted at USD1.2619 early on Tuesday in London, higher compared to USD1.2571 at the equities close on Friday. The euro stood at USD1.0818, up against USD1.0783. Against the yen, the dollar was trading at JPY146.43, higher compared to JPY146.27.

In the FTSE 100, Bunzl was the best performer, up 3.7%.

The London-based distribution services company reported revenue of GBP5.91 billion in the six months ended June 30, up 4.5% from GBP5.65 billion a year earlier. Pretax profit increased by 6.9% to GBP317.1 million from GBP296.6 million.

The company upped its interim dividend by 5.2% to 18.2p from 17.3p.

Also, Bunzl said it has signed an agreement to acquire a business in Poland, and also acquired a business in the Netherlands.

Rio Tinto rose 1.6%.

It said it has completed the agreement to sell a majority stake in the La Granja copper project in Peru to First Quantum Minerals, banking just over USD100 million and gaining a partner who will invest another half billion into the project.

La Granja, located high in the mountains in Cajamarca, northern Peru, is one of the largest undeveloped copper deposits in the world, Rio said. It has an indicated and inferred mineral resource totalling 4.32 billion tonnes at 0.51% copper. First Quantum will become the operator of the mine.

The agreement to sell a 55% stake in La Granja to First Quantum was first announced back in March. Rio on Tuesday said the completion follows regulatory approvals from the government of Peru, from which the Anglo-Australian miner had purchased the project back in 2006.

In the FTSE 250, PureTech Health rose 4.2%.

The US-based biotherapeutics company's pretax loss narrowed to USD13.7 million in the first half of 2023 from USD56.0 million a year earlier.

However, its revenue fell to USD3.2 million in the first half of 2023, from USD7.0 million.

Founder & Chief Executive Officer Daphne Zohar, said: "The first half of 2023 has been a strong period across both our Founded Entities and Wholly Owned Pipeline. We have achieved important clinical and financial milestones, while executing on our mission of giving life to new classes of medicine to change the lives of patients with devastating diseases."

On London's AIM, Pelatro plummeted 60%.

It said that it is seeking cancellation of trading of its shares, as it considers being listed to be no longer in the best interest of the company.

Pelatro noted the "considerable cost, management time and the legal and regulatory burden" associated with its listing.

It also said that Chief Financial Officer Nic Hellyer has resigned.

Chair Harry Berry said: "Nic has been with Pelatro since before our IPO in December 2017 and has made a significant contribution to the growth of the company since then. We wish him well for his future endeavours."

In Asia on Tuesday, the Nikkei 225 index in Tokyo closed up 0.2%. The S&P/ASX 200 in Sydney closed up 0.7%.

The Shanghai Composite closed up 1.2%, while the Hang Seng index in Hong Kong was up 1.9% in late trade. Chinese stocks extended Monday's gains after China's regulators decided to slash the tax paid on stock trades for the first time since 2008, and pledged to slow the pace of initial public offerings, which typically suck up market liquidity.

In European equities on Tuesday, the CAC 40 in Paris was up 0.2%, while the DAX 40 in Frankfurt was up 0.3%, having closed up 1.3% and 1.0% respectively on Monday.

German consumer sentiment is expected to worsen in September, according to new figures from GfK on Tuesday.

Pollster GfK said its forward-looking survey fell to minus 25.5 points in September from a revised minus 24.6 points in August. FXStreet-cited market consensus had expected the figure to come in at a slightly better minus 24.3 points.

"The consumer sentiment is currently not showing a clear trend, neither downward nor upward – and that at a very low level overall," explained Rolf Burkl, GfK consumer expert.

"The chances that consumer sentiment can sustainably recover before the end of this year are dwindling more and more. Persistently high inflation rates, especially for food and energy supplies, ensure that the consumer sentiment is currently not making any progress."

In the US on Monday, Wall Street ended higher, with the Dow Jones Industrial Average and the S&P 500 both up 0.6%, and the Nasdaq Composite up 0.8%.

It will be a data-heavy week in the US, with a gross domestic product reading on Wednesday, the Fed's preferred inflationary gauge on Thursday and the latest jobs report on Friday.

Gold was quoted at USD1,922.71 an ounce early Tuesday, higher than USD1,906.88 on Friday. Brent oil was trading at USD83.73 a barrel early Tuesday, higher than USD83.57 late Friday.

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
11 Oct 2022 07:54

LONDON BRIEFING: Bank of England widens bond buying; UK jobless down

(Alliance News) - The mood in global markets remained dark early Tuesday, with poor sessions in New York and Asia set to spill over to the European open.

Read more
11 Oct 2022 07:05

Puretech, Nektar Therapeutics end merger talks

(Sharecast News) - Shares in healthcare company PureTech fell on Tuesday as the company said it and US-based Nektar Therapeutics had ended merger talks only four days after they announced a potential tie up.

Read more
7 Oct 2022 09:51

TOP NEWS: PureTech Health in merger talks with Nektar Therapeutics

(Alliance News) - Clinical-stage biotherapeutics firm PureTech Health PLC on Friday confirmed it is in combination talks with San Francisco-based biopharmaceutical company Nektar Therapeutics Inc.

Read more
7 Oct 2022 07:10

Puretech Health confirms possible tie-up with Nektar Therapeutics

(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.

Read more
7 Oct 2022 07:10

Puretech Health confirms possible tie-up with Nektar Therapeutics

(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.

Read more
5 Sep 2022 11:40

IN BRIEF: PureTech Health data on fibrosis drug candidate positive

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Posts positive data from a phase 1 trial of its idiopathic pulmonary fibrosis drug candidate LYT-100, or deupirfenidone.

Read more
31 Aug 2022 20:31

TOP NEWS: ConvaTec to join FTSE 100 as abrdn vacates spot

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, September 19 after completing its quarterly review.

Read more
25 Aug 2022 16:26

TRADING UPDATES: Malvern revenue jumps; Rockwood eyes Main Market

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Aug 2022 11:03

SMALL-CAP WINNERS & LOSERS: Hunting surges as loss narrows, ups payout

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.

Read more
25 Aug 2022 10:10

IN BRIEF: PureTech Health loss narrows in "exceedingly strong" half

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Pretax loss in the first half 2022 narrows to USD56.0 million from USD94.9 million a year before. This is due to a USD28.4 million gain on the dilution of its equity interest in Gelesis Inc. Revenue grows 21% to USD7.0 million from USD5.8 million. Attributes this to increased grant revenue from the Vedanta CARB-X and BARDA grant, as well as Alivio and PureTech LYT Inc.

Read more
25 Aug 2022 09:25

PureTech first-half mixed as it makes good clinical progress

(Sharecast News) - PureTech Health reported total first-half revenue of $7.03m on Thursday, up from $5.84m year-on-year.

Read more
24 Aug 2022 17:58

IN BRIEF: PureTech Health's Sonde Health signs deal for COPD in India

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says its founded entity, Sonde Health, has signed a multi-year agreement with specialty pharmaceutical company Koye Pharmaceuticals Pvt Ltd. The agreement is to develop a new vocal biomarker detection and monitoring capability for chronic obstructive pulmonary disease in India. This is Sonde's first partnership with a pharmaceutical firm, PureTech adds.

Read more
23 Aug 2022 18:14

TOP NEWS: abrdn indicated to drop out of FTSE 100, F&C to join

(Alliance News) - Almost 18 months after announcing a name change, abrdn PLC's blue-chip status is under threat, according to indicative index changes provided by FTSE Russell on Tuesday.

Read more
22 Aug 2022 09:15

PureTech Health's Akili raises USD163 million via Nasdaq IPO

(Alliance News) - PureTech Health PLC said founded entity Akili Inc will start trading on the Nasdaq Capital Market on Monday, after raising funds which will go towards video-game based treatment for children.

Read more
9 Aug 2022 09:31

PureTech gets USD115 million from sale of Karuna Therapeutics shares

(Alliance News) - PureTech Health PLC on Tuesday announced it received USD115.4 million after selling a portion of its stake in Karuna Therapeutics Inc.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.